# Valtech Cardio

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/valtech-cardio

- Industry: Healthcare Specialists
- Headquarters: Or Yehuda, Israel
- Website: www.valtechcardio.com
- Total disclosed funding: $18M
- Latest round: Series B (Feb 2, 2010)
- Investors on record: 3

## About

Valtech Cardio Ltd. is a medical technology company specializing in innovative solutions for heart valve disorders. They focus on enhancing patient outcomes through their advanced therapeutic devices.Valtech Cardio Ltd. was founded in 2006 in Or Yehuda, Israel. The company is dedicated to developing advanced solutions for heart valve diseases. In September 2015, HeartWare agreed to acquire Valtech Cardio Ltd. The company has successfully raised a total of USD 17.80 mn through various funding rounds, including its latest Series B round, which raised USD 17.80 mn from investors such as NGN Capital, OXO Capital Valve Ventures, and Peregrine Ventures.Valtech Cardio specializes in innovative medical technologies that address heart valve disease. Their core product offerings focus on transcatheter heart valves and advanced monitoring systems tailored for the treatment of cardiovascular conditions, thus catering to healthcare professionals globally, including cardiologists and surgeons.Valtech Cardio generates revenue through direct sales of its innovative heart valve technologies to healthcare institutions, leveraging a business-to-business model. Revenue primarily comes from the sale of transcatheter heart valves and related advanced medical devices, which are integral to surgical and critical care procedures.Moving forward, Valtech Cardio is focused on expanding its product line with new devices aimed at addressing cardiovascular conditions more effectively. The recent funding will be strategically utilized to enhance research and development initiatives. Additionally, the company is exploring opportunities to enter new geographic markets, although specific regions have not yet been disclosed.

## Funding rounds

- Series B, Feb 2, 2010, $18M — NGN Capital, Peregrine Ventures, OXO Capital Valve Ventures

## Investors

- NGN Capital (https://capitalatlas.ai/funds/ngn-capital) — Series B
- Peregrine Ventures (https://capitalatlas.ai/funds/peregrine-ventures) — Series B
- OXO Capital Valve Ventures — Series B